U. Wagner

Quantitative EEG: investigation in children with end stage renal disease before and after haemodialysis.

B. Saletu, E. Balzar, A. Khoss, 1986, Clinical EEG.

Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response

H. Lorenz, C. Fiehn, N. Blank, 2016, Journal of Rheumatology.

[Renal oncocytomatosis].

H. Moch, J. Richter, W. Wegmann, 1999, Der Pathologe.

Metastasising malignant lymphoma mimicking necrotising and hyperplastic gingivostomatitis.

E. Haneke, S. Born, W. Marsch, 1999, EJD. European journal of dermatology.

Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response

H. Lorenz, C. Fiehn, N. Blank, 2016, The Journal of Rheumatology.